All Updates

All Updates

icon
Filter
Funding
Seamless Therapeutics raises EUR 11.8 million in seed funding
Human Gene Editing
Mar 16, 2023
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
Human Gene Editing

Human Gene Editing

Mar 16, 2023

Seamless Therapeutics raises EUR 11.8 million in seed funding

Funding

  • Gene editing company Seamless Therapeutics has raised EUR 11.8 million (USD 12.5 million) in a seed financing round co-led by Wellington Partners and Forbion. The raised funds included non-dilutive financing from BMBF GO-Bio, an initiative by the German government. 

  • The Germany-based company follows a gene-editing approach that develops designer recombinases: programmable enzymes that are reportedly capable of editing substantial portions of genes, unlike natural recombinases that work on very specific target sequences. The company plans to use the funding to further develop its technology platform and expand its presence in the EU and US.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.